State of the Science and Future Directions for Liquid Biopsies in Drug Development

Oncologist. 2020 Sep;25(9):730-732. doi: 10.1634/theoncologist.2020-0246. Epub 2020 Jun 29.

Abstract

With advances in precision oncology, liquid biopsies have shown promise as a minimally invasive means to diagnose cancer and guide treatment decisions. This commentary presents an assessment of the potential and the challenges of widespread use of liquid biopsy testing, based on the 2019 Accelerating Anticancer Agent Development Workshop.

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor*
  • Drug Development*
  • Humans
  • Liquid Biopsy

Substances

  • Biomarkers, Tumor